These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

243 related articles for article (PubMed ID: 23220912)

  • 1. Reduced microRNA-150 is associated with poor survival in pulmonary arterial hypertension.
    Rhodes CJ; Wharton J; Boon RA; Roexe T; Tsang H; Wojciak-Stothard B; Chakrabarti A; Howard LS; Gibbs JS; Lawrie A; Condliffe R; Elliot CA; Kiely DG; Huson L; Ghofrani HA; Tiede H; Schermuly R; Zeiher AM; Dimmeler S; Wilkins MR
    Am J Respir Crit Care Med; 2013 Feb; 187(3):294-302. PubMed ID: 23220912
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Circulating microRNA as a Novel Biomarker for Pulmonary Arterial Hypertension Due to Congenital Heart Disease.
    Chen W; Li S
    Pediatr Cardiol; 2017 Jan; 38(1):86-94. PubMed ID: 27837306
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MicroRNA-17 as a potential diagnostic biomarker in pulmonary arterial hypertension.
    Li H; Yang Z; Gao F; Zhang Y; Meng W; Rong S
    J Int Med Res; 2020 Jun; 48(6):300060520920430. PubMed ID: 32600075
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impaired angiogenesis and peripheral muscle microcirculation loss contribute to exercise intolerance in pulmonary arterial hypertension.
    Potus F; Malenfant S; Graydon C; Mainguy V; Tremblay È; Breuils-Bonnet S; Ribeiro F; Porlier A; Maltais F; Bonnet S; Provencher S
    Am J Respir Crit Care Med; 2014 Aug; 190(3):318-28. PubMed ID: 24977625
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Discordant Regulation of microRNA Between Multiple Experimental Models and Human Pulmonary Hypertension.
    Schlosser K; Taha M; Deng Y; Jiang B; Stewart DJ
    Chest; 2015 Aug; 148(2):481-490. PubMed ID: 25763574
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dynamic changes in lung microRNA profiles during the development of pulmonary hypertension due to chronic hypoxia and monocrotaline.
    Caruso P; MacLean MR; Khanin R; McClure J; Soon E; Southgate M; MacDonald RA; Greig JA; Robertson KE; Masson R; Denby L; Dempsie Y; Long L; Morrell NW; Baker AH
    Arterioscler Thromb Vasc Biol; 2010 Apr; 30(4):716-23. PubMed ID: 20110569
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reversal of MicroRNA Dysregulation in an Animal Model of Pulmonary Hypertension.
    Gubrij IB; Pangle AK; Pang L; Johnson LG
    PLoS One; 2016; 11(1):e0147827. PubMed ID: 26815432
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A diagnostic miRNA signature for pulmonary arterial hypertension using a consensus machine learning approach.
    Errington N; Iremonger J; Pickworth JA; Kariotis S; Rhodes CJ; Rothman AM; Condliffe R; Elliot CA; Kiely DG; Howard LS; Wharton J; Thompson AAR; Morrell NW; Wilkins MR; Wang D; Lawrie A
    EBioMedicine; 2021 Jul; 69():103444. PubMed ID: 34186489
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression and clinical significance of miR-8078 in patients with congenital heart disease-associated pulmonary arterial hypertension.
    Zhang W; Hua Y; Zheng D; Chen Q; Huang R; Wang W; Li X
    Gene; 2024 Feb; 896():147964. PubMed ID: 37926175
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MicroRNA-138 and MicroRNA-25 Down-regulate Mitochondrial Calcium Uniporter, Causing the Pulmonary Arterial Hypertension Cancer Phenotype.
    Hong Z; Chen KH; DasGupta A; Potus F; Dunham-Snary K; Bonnet S; Tian L; Fu J; Breuils-Bonnet S; Provencher S; Wu D; Mewburn J; Ormiston ML; Archer SL
    Am J Respir Crit Care Med; 2017 Feb; 195(4):515-529. PubMed ID: 27648837
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identifying microRNAs targeting Wnt/β-catenin pathway in end-stage idiopathic pulmonary arterial hypertension.
    Wu D; Talbot CC; Liu Q; Jing ZC; Damico RL; Tuder R; Barnes KC; Hassoun PM; Gao L
    J Mol Med (Berl); 2016 Aug; 94(8):875-85. PubMed ID: 27188753
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serum endostatin is a genetically determined predictor of survival in pulmonary arterial hypertension.
    Damico R; Kolb TM; Valera L; Wang L; Housten T; Tedford RJ; Kass DA; Rafaels N; Gao L; Barnes KC; Benza RL; Rand JL; Hamid R; Loyd JE; Robbins IM; Hemnes AR; Chung WK; Austin ED; Drummond MB; Mathai SC; Hassoun PM
    Am J Respir Crit Care Med; 2015 Jan; 191(2):208-18. PubMed ID: 25489667
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression of the microRNA-30 family in pulmonary arterial hypertension and the role of microRNA-30d-5p in the regulation of pulmonary arterial smooth muscle cell toxicity and apoptosis.
    Hu F; Liu H; Wang C; Li H; Qiao L
    Exp Ther Med; 2022 Jan; 23(1):108. PubMed ID: 34976150
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Circulating levels of copeptin predict outcome in patients with pulmonary arterial hypertension.
    Nickel NP; Lichtinghagen R; Golpon H; Olsson KM; Brand K; Welte T; Hoeper MM
    Respir Res; 2013 Nov; 14(1):130. PubMed ID: 24251953
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MicroRNA-140 is elevated and mitofusin-1 is downregulated in the right ventricle of the Sugen5416/hypoxia/normoxia model of pulmonary arterial hypertension.
    Joshi SR; Dhagia V; Gairhe S; Edwards JG; McMurtry IF; Gupte SA
    Am J Physiol Heart Circ Physiol; 2016 Sep; 311(3):H689-98. PubMed ID: 27422986
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hepatoma-derived Growth Factor Predicts Disease Severity and Survival in Pulmonary Arterial Hypertension.
    Yang J; Nies MK; Fu Z; Damico R; Korley FK; Hassoun PM; Ivy DD; Austin ED; Everett AD
    Am J Respir Crit Care Med; 2016 Nov; 194(10):1264-1272. PubMed ID: 27254543
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Red cell distribution width outperforms other potential circulating biomarkers in predicting survival in idiopathic pulmonary arterial hypertension.
    Rhodes CJ; Wharton J; Howard LS; Gibbs JS; Wilkins MR
    Heart; 2011 Jul; 97(13):1054-60. PubMed ID: 21558476
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Resistin predicts disease severity and survival in patients with pulmonary arterial hypertension.
    Gao L; Skinner J; Nath T; Lin Q; Griffiths M; Damico RL; Pauciulo MW; Nichols WC; Hassoun PM; Everett AD; Johns RA
    Respir Res; 2024 Jun; 25(1):235. PubMed ID: 38844967
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MicroRNA-140-5p targeting tumor necrosis factor-α prevents pulmonary arterial hypertension.
    Zhu TT; Zhang WF; Yin YL; Liu YH; Song P; Xu J; Zhang MX; Li P
    J Cell Physiol; 2019 Jun; 234(6):9535-9550. PubMed ID: 30367500
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MicroRNA-424(322) as a new marker of disease progression in pulmonary arterial hypertension and its role in right ventricular hypertrophy by targeting SMURF1.
    Baptista R; Marques C; Catarino S; Enguita FJ; Costa MC; Matafome P; Zuzarte M; Castro G; Reis A; Monteiro P; Pêgo M; Pereira P; Girão H
    Cardiovasc Res; 2018 Jan; 114(1):53-64. PubMed ID: 29016730
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.